| Sandig, Volker (ProBioGen 201004 promoted CSO since 2000 at ProBiogGen before Merck US) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Minapharm (Group) |
Germany |
| Sandin, Mary Beth (Affimed 202101 Head of Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Sando, Gregg (Cell Medica 2006–201807 CEO + Founder RESIGNED 8/18) |
Chief Executive Officer (CEO) |
Cell Medica (Group) |
United Kingdom (GB) |
| Sandor, Victor (ADC Therapeutics 202004– Board Director before CMO at Array BioPharma + Incyte + Biogen Idec + AZ) |
Board member, non-executive |
ADC Therapeutics (Group) |
Switzerland |
| Sanghera, Jas (TTP Labtech 201606– Chairman before Managing Director + Commercial Director + Co-founder) |
Board member, non-executive |
TTP Labtech (Group) |
United Kingdom (GB) |
| Sansawat, Supreeya (SGS 201012 Global Manager of Food Services) |
n. a. |
SGS (Group) |
Switzerland |
| Santagostino, Alberto (Lonza 201906 SVP Head of Cell + Gene Technologies at Lonza Pharma + Biotech) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Santarelli, Luca (Roche 201110 Global Head Neuroscience Disease Translational Area) |
Research & Development Manager |
Roche (Group) |
Switzerland |
| Santel, Donald J. (Hyperion Therapeutics 200806– CEO before CoTherix CEO) |
Chief Executive Officer (CEO) |
Horizon Therapeutics (Group) |
United States (USA) |
| Santner, Friedrich (Anton Paar 201311 CEO) |
Chief Executive Officer (CEO) |
Anton Paar (Group) |
Austria |
| Santner, Roswitha (Applera Seutschland 200809) |
n. a. |
Thermo Fisher (Group) |
Germany |
| Santoro, Massimo (Schauenburg 201412– Technical Marketing Director at Markes before Thermo Fisher + PerkinElmer) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Sanyal, Sunny (Varian Medical Systems 201412 President Varian Imaging Components) |
President/Director/Head Business Group/Unit/Division |
Varian Medical Systems (Group) |
United States (USA) |
| Sargent, William (Will) (Nabriva 201510– VP Commercial Strategy + IR before Auxilium + BofA + Amgen + Immunex) |
Corporate Strategy Manager |
Nabriva (Group) |
United States (USA) |
| Sarronwala, Sudhanshu (Suds) (Infarm 202012 Chief Impact Officer) |
n. a. |
Infarm – Indoor Urban Farming GmbH |
Germany |
| Sarto, Christian (Bayer 201307– Managing Director of Steigerwald GmbH before Bayer HealthCare M&A) |
Managing Director |
Bayer (Group) |
Germany |
| Sarx, Johannes (Austria (govt) 201310 Managing Direcor of LISAvienna) |
Managing Director |
Austria (govt) |
Austria |
| Sasov, Alexander (Bruker 201204– Managing Director of Bruker microCT before SkyScan NV CEO + founder) |
Managing Director |
Bruker (Group) |
Belgium |
| Sasshofer, Siegfried (Tecan 200702 Head Marketing Detection Business) |
Sales Manager / Marketing Manager |
Tecan (Group) |
|
| Sato, Vicki (Harvard Univ 2001104 Prof + Atlas Venture Business Adivisor before Vertex President + CSO before Biogen) |
Board member, non-executive |
Harvard University |
United States (USA) |
| Sauer, Dirk (Novartis 202012 Head of Ophthalmology Franchise at Novartis Pharma AG( |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Sauer, Uwe (ETH Zurich 201007 Institute of Molecular Systems Biology) |
Researcher (university / research institute) |
ETH Zürich (ETHZ) |
Switzerland |
| Sauer-Odendahl, Bastian (Evotec 201307– Global Head of Human Resources) |
Human Resources Manager |
Evotec (Group) |
Germany |
| Sauermann, Stefan (AnagnosTec 200912 CEO + CFO joined 2/02 as CFO) |
Managing Director |
AnagnosTec Gesellschaft für Analytische Biochemie und Diagnostik mbH |
Germany |
| Saunders, Andrew (Redx Pharma 201801– CMO before Lytix Biopharma + Linden Oncology Ltd + Eli Lilly + Roche) |
Chief Medical Officer (CMO) |
Lytix Biopharma AS |
Norway |
| Saunders, Lee (Dentons 201412 PR + Communications Manager UKMEA) |
Public Relations Manager / Investor Relations Manager |
Dentons (Group) |
United Kingdom (GB) |
| Sauter, Eberhard (Helmholtz 200908 Alfred Wegener Institute) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Savage, Karen (Rentschler 201911 VP + Head of Milford Site) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
| Savelkoul, Paul (Microbiome 201503 CEO) |
Chief Executive Officer (CEO) |
Microbiome (NL) |
Netherlands |
| Savitsky, Alexander (AN Bach Institute 201109) |
Professor |
Russian Academy of Sciences (RAS/EIMB) |
Russian Federation |
| Savitsky, Kinneret (FuturX 202012 CEO before BioLineRx 201001–201610 CEO joined 2004 before BioLine Innovations + CGEN) |
Chief Executive Officer (CEO) |
FutuRx Ltd. Biotechnology Incubator |
Israel |
| Savitzky, Rodolfo (Lonza 201801 CFO) |
Chief Financial Officer (CFO) |
Lonza (Group) |
Switzerland |
| Saxton, Tracy (Nan Fung 2201703– Managing Partner + Founder of Pivotal BioVenture Partners) |
Managing Partner (investment firm) |
Nan Fung (Group) |
United States (USA) |
| Saynor, Richard (Novartis 2019Q1– CEO of Sandoz) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Germany |
| Scangos, George A. (Biogen Idec 201007– CEO before Exelixis 199611– CEO before Bayer) |
Chief Executive Officer (CEO) |
Biogen (Group) |
United States (USA) |
| Scarrott, Alison (Chaz Brooks Communciations 201209 Account Manager) |
Public Relations Manager / Investor Relations Manager |
Chaz Brooks Communications Ltd. (CBC) |
United Kingdom (GB) |
| Schaaf, Andreas (Greenovation Biotech 201911– Managing Director) |
Managing Director |
Eleva GmbH |
Germany |
| Schacherer, Frank (Biobase 201105 Managing Director (COO) joined Biobase 2005 as Director Biobase Corp) |
Managing Director |
Qiagen (Group) |
Germany |
| Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO) |
Chief Executive Officer (CEO) |
Curetis (Group) |
Germany |
| Schad, Martina (OakLabs GmbH 201103–Managing Director + founder before imaGenes Assoc Director Microarray Services) |
Managing Director |
OakLabs GmbH |
Germany |
| Schaefer, Burkhard (BSSN Software GmbH 201908 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Schaeske, Frank (Mettler-Toledo GmbH 201711 Senior Marcom Manager LAB + Product Manager Analytical Instruments) |
Sales Manager / Marketing Manager |
Mettler-Toledo (Group) |
Germany |
| Schafberger, Bernd (Bayer (govt) 201409 Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Schaffarczyk, Dietmar Stefan (stimOS GmbH 201707 Managing Director) |
Managing Director |
|
|
| Schaffer, Thomas (Biofrontera 201306– CFO before Siemens et al) |
Chief Financial Officer (CFO) |
Biofrontera (Group) |
Germany |
| Schaffert, Susanne (Novartis 201901– CEO of Oncology Business Unit joined Novartis more than 20 years ago) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Schaier, Matthias (TolerogenixX GmbH 201612– Managing Director) |
Managing Director |
TolerogenixX GmbH |
Germany |
| Schalken, Jack (Univ Nijmegen 2013 Professor + Founder of Oncodrone BV) |
Professor |
University of Nijmegen (Radboud University) |
Netherlands |
| Schalper, Claus (XL-protein 201410 Managing Director (CEO) before Pieris 201101 CFO) |
Managing Director |
XL-protein GmbH (XLp) |
Germany |
| Schambye, Hans T. (Galecto Biotech 201111– CEO before OncoNOx + Reception + Gastrotech + Maxygen + ProFound Pharma) |
Chief Executive Officer (CEO) |
Galecto (Group) |
Denmark |
| Schanche, Jon-Sverre (Thermo Fisher 201605 VP RnD for ImmunoDiagnostics business) |
Research & Development Manager |
Thermo Fisher (Group) |
United States (USA) |
| Schapeler, Dirk (Bayer 201711 Head of LifeScience iHUB) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
United States (USA) |
| Scharrer, Nicola (ITM Isotopen Technologien München 201603 Head of Marketing) |
Sales Manager / Marketing Manager |
ITM Isotopen Technologien München AG |
Germany |
| Schatz, Peer M. (Resolve BioSciences 202012 Chairman + Co-Founder before Qiagen 1993–201910 CEO RESIGNED 10/19) |
Board member, non-executive |
Resolve Biosciences GmbH |
Germany |
| Schaub, Christian (Redbiotec 201501 CEO) |
Chief Executive Officer (CEO) |
Redbiotec AG |
Switzerland |
| Schaude, Michael (Quantapore 201406 Board Member before Bender MedSystems 1998–2009 CEO + Boehringer) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
Austria |
| Schauenburg, Florian G. (Schauenburg 201301 CEO) |
Chief Executive Officer (CEO) |
Schauenburg (Group) |
Germany |
| Schauer, Nicolas (Biocrates 201909– Co-CEO + CSO before Metabolomic Discoveries Managing Director + Founder) |
Managing Director |
Metabolon (Group) |
Germany |
| Schavan, Annette (BMBF 2006) |
n. a. |
Germany (govt) |
Germany |
| Scheefers, Hans (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefers-Borchel, Ursula (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefhals, Guus (Crossbeta Biosciences 201303 CEO) |
Chief Executive Officer (CEO) |
Crossbeta Biosciences B.V. |
Netherlands |
| Scheek, Sigrid (Ascenion 200801 Technology Manager) |
IP Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Scheel, Andreas (Evotec 202004 EVP Head of Cell Therapy + PanCella 202004– Supervisory Board Member) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Scheer, Alexander (Erytech 201610– CSO before Pierre Fabre + Merck Serono + Serono) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Erytech (Group) |
France |
| Scheer, Nico (Cevec 201511– VP Business Development Glycoproteins before Taconic Biosciences/Artemis) |
Business Development Manager / Strategy Manager |
Cevec (Group) |
Germany |
| Scheffer, Petra (Bruker Corp 201701 Director of MarCom at Bruker Daltonics) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Scheffler, Matthias (Biocrates 201911 CBO + Head Marketing + Sales before Febit) |
Chief Business Officer (CBO) |
Biocrates (Group) |
Austria |
| Schefold, Christian (Dentons 201501– Counsel before Counsel at Daimler + Daimler Financial Services) |
Attorney / Lawyer |
Dentons (Group) |
Switzerland |
| Scheibner, Holger (IMI Consulting 200503) |
n. a. |
IMI Consulting GmbH |
Germany |
| Scheidegger, Alfred (Nextech Invest 201104 CEO + Founding Partner) |
Chief Executive Officer (CEO) |
Nextech (Group) |
Switzerland |
| Scheidle, Jörg (Immatics 200501– CFO before BrainLab) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Germany |
| Scheiflinger, Friedrich (Fritz) (Evotec 202004 EVP Head Gene Therapy before Shire/Takeda 201707 Head Global Research) |
President/Director/Head Business Group/Unit/Division |
Evotec Gene Therapy (Orth, AT, Evotec GT) |
Austria |
| Scheinert, Peter (AmpTec GmbH 201201 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Scheipers, Andreas (sense2care 201101 Managing Director) |
Managing Director |
sense2care GmbH |
Germany |
| Scheitza, Rüdiger (Bayer CropScience 200504) |
n. a. |
Bayer (Group) |
Germany |
| Schelhorn, Thomas (Hologic 201304 Hologic/Gen-Probe Senior Marketing Manager Europe HPV) |
Sales Manager / Marketing Manager |
Hologic (Group) |
Germany |
| Schell, Simone (Trelleborg 201704 Project Developm Engineer Life Sciences Europe at Trelleborg Sealing DE) |
Business Development Manager / Strategy Manager |
Trelleborg (Group) |
Germany |
| Scheller, Frieder W. |
n. a. |
University of Potsdam |
Germany |
| Scheller, Ulrich (BBB Management GmbH Campus Berlin-Buch 201104 Managing Director) |
Managing Director |
BBB Management GmbH Campus Berlin-Buch (BiotechPark Berlin-Buch) |
Germany |
| Scheltema, Richard (Univ Utrecht 202008 at Heck lab) |
Researcher (university / research institute) |
University of Utrecht (Utrecht University) |
Netherlands |
| Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München) |
Chief Executive Officer (CEO) |
Medigene (Group) |
Germany |
| Schenk, Alexander (SeSaM-Biotech 200811– Managing Director + Co-Founder before Jacobs Univ) |
Managing Director |
SeSaM-Biotech GmbH |
Germany |
| Schenk, Dale B. (Prothena 2012–2016 CEO + Co-Founder before Élan DIED 9/16) |
Chief Executive Officer (CEO) |
Prothena (Group) |
Ireland, Republic of |
| Schenke-Layland, Katja (Univ Tübingen 201805 Prof + Managing Director of NMI) |
Managing Director |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Schenkel, Anke (Merck (DE) 201704– Head of Group Controlling & Risk Management joined 2010 before PWC) |
Controller (management) |
Merck (DE) (Group) |
Germany |
| Schepp, Jim (Diatron 201603 CEO) |
Chief Executive Officer (CEO) |
Stratec (Group) |
Hungary |
| Scher, Irwin (Biosynexus 200506– CEO before Merck KGaA) |
Chief Executive Officer (CEO) |
QVT Fund L.P. |
United States (USA) |
| Scherbel, Ulrich (AMSilk 202101– CEO joined as COO 202010 before Global Apparel Division of Freudenberg) |
Chief Executive Officer (CEO) |
AMSilk GmbH |
Germany |
| Scherer, Dieter (Novaliq GmbH 200904– CBO before Apis Pharma + SKyePharma CH + LTS Lohmann) |
Chief Business Officer (CBO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Scherer, Jörg (EURICE 201201 Managing Director) |
Managing Director |
European Research and Project Office GmbH (EURICE) |
Germany |
| Scherer, Mirko (MPM Capital 201207– Managing Director Munich + KI Capital before GPC Biotech CFO) |
Managing Director |
MPM Capital (Group) |
Germany |
| Scherer, Stefan (Alicona 201811 Managing Director) |
Managing Director |
Bruker (Group) |
Austria |
| Scherer, Stefan (Biocartis 201303– CMO before Roche/Genentech + Grünenthal) |
Chief Medical Officer (CMO) |
Biocartis (Group) |
Switzerland |
| Scherhag, Rudi (Neuway Pharma 201508– Managing Director before ImClone Systems + Heidelberg Pharma + Roche Mannheim) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Schermeier, Olaf (Fresenius 201911 CEO for Global RnD of Fresenius Medical Care) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
Germany |
| Scherrer, Frank (Wenger & Vieli 200809 Zurich) |
n. a. |
Wenger & Vieli Attorneys at Law (Zurich) |
Switzerland |
| Scherz, Michael, Ph.D. (Metys Pharmaceuticals 201304– CEO + Co-Founder before Actelion 2000–2012 + P&G Pharma) |
Chief Executive Officer (CEO) |
Metys Pharmaceuticals AG |
Switzerland |
| Schetter, Christian (Arix Bioscience 201812– Entrepreneur In Residence before Rigontec + Fresenius Biotech + Coley GmbH) |
Investment Manager |
Arix Bioscience (Group) |
United Kingdom (GB) |
| Scheuble, Bernhard (Merck KGaA –200511) |
n. a. |
Merck (DE) (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 55 56 57 ... 73 74 75 
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
